BioSpace News Archive

Drug Development

MoonLake Immunotherapeutics to initiate global Phase 2 study of the Nanobody® sonelokimab in patients with active psoriatic arthritis

MoonLake Immunotherapeutics to initiate global Phase 2 study of the Nanobody® sonelokimab in patients with active psoriatic arthritis.

September 26, 2022
·
9 min read
HTG Molecular Diagnostics to Participate in the Cantor Fitzgerald Oncology, Hematology & HemeOnc Conference

HTG Molecular Diagnostics, Inc. today announced that management will participate in the Cantor Fitzgerald Oncology, Hematology & HemeOnc Conference at the Lotte New York Palace in New York City on Wednesday, September 28, 2022.

September 26, 2022
·
1 min read
Biotech Bay

Surrozen Publishes Study in Translational Vision Science and Technology Demonstrating the Promise of SZN-413 in Preclinical Models of Diabetic Retinopathy

Surrozen, Inc. announced today the publication of an article by Surrozen scientists in the journal Translational Vision Science and Technology.

September 26, 2022
·
7 min read
Business

Phathom Pharmaceuticals Appoints Dr. James Topper to its Board of Directors

Phathom Pharmaceuticals, Inc. today announced the appointment of James “Jamie” Topper, M.D., Ph.D., to its Board of Directors.

September 26, 2022
·
3 min read
Biotech Beach

Erasca to Present at the Bank of America Securities Precision Oncology Conference 2022

Erasca, Inc. today announced its participation in the Bank of America Securities Precision Oncology Conference.

September 26, 2022
·
1 min read
Drug Development

Arcutis Announces Positive Topline Results from ARRECTOR Pivotal Phase 3 Trial of Roflumilast Foam 0.3% in Scalp and Body Psoriasis

Arcutis Biotherapeutics, Inc. today announced positive topline results from the ARRECTOR Pivotal Phase 3 trial evaluating roflumilast foam 0.3%, a once-daily, non-steroidal topical phosphodiesterase-4 (PDE4) inhibitor, for the treatment of adults and adolescents with scalp and body psoriasis.

September 26, 2022
·
9 min read
Business

eFFECTOR Therapeutics Appoints Mayank Gandhi, M.D., as Chief Business Officer

eFFECTOR Therapeutics, Inc. today announced it has appointed Mayank J. Gandhi, M.D., as chief business officer.

September 26, 2022
·
5 min read
Smith+Nephew first to market with revision knee indication on robotics platform

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces the first cases for revision knee replacement utilizing its CORI◊ Surgical System.

September 26, 2022
·
8 min read
BioCapital

Infectious Diseases Society of America Foundation Announces Applications for Microbial Pathogenesis in Alzheimer’s Research Grant

The Infectious Diseases Society of America Foundation is now accepting applications for the Microbial Pathogenesis in Alzheimer’s Disease Grant.

September 26, 2022
·
2 min read
FDA

Pulse Biosciences Announces FDA 510(k) Clearance for the Treatment of Sebaceous Hyperplasia

Pulse Biosciences, Inc. today announced receipt of U.S. Food and Drug Administration (FDA) 510(k) clearance for its CellFX System.

September 26, 2022
·
4 min read